BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21172434)

  • 1. Novel extended-release formulation of lovastatin by one-step melt granulation: in vitro and in vivo evaluation.
    Ochoa L; Igartua M; Hernández RM; Gascón AR; Solinis MA; Pedraz JL
    Eur J Pharm Biopharm; 2011 Feb; 77(2):306-12. PubMed ID: 21172434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.
    Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL
    Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel mesoporous nanomatrix-supported lipid bilayers for oral sustained delivery of the water-insoluble drug, lovastatin.
    Zhang Y; Zhang H; Che E; Zhang L; Han J; Yang Y; Wang S; Zhang M; Gao C
    Colloids Surf B Biointerfaces; 2015 Apr; 128():77-85. PubMed ID: 25731096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.
    Jenner P; Könen-Bergmann M; Schepers C; Haertter S
    Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin.
    Guo M; Fu Q; Wu C; Guo Z; Li M; Sun J; He Z; Yang L
    Colloids Surf B Biointerfaces; 2015 Apr; 128():410-418. PubMed ID: 25766921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redispersible, dry emulsion of lovastatin protects against intestinal metabolism and improves bioavailability.
    Ge Z; Zhang XX; Gan L; Gan Y
    Acta Pharmacol Sin; 2008 Aug; 29(8):990-7. PubMed ID: 18664332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lovastatin extended-release dosage form (Lovastatin XL) in healthy volunteers.
    Lamson M; Phillips G; Shen J; Lukacsko P; Friedhoff L; Niecestro RM
    Biopharm Drug Dispos; 2002 May; 23(4):143-9. PubMed ID: 12015788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
    Quan DQ; Xu GX
    Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of lovastatin extended-release tablets and lovastatin immediate-release tablets in humans.
    Sun JX; Niecestro R; Phillips G; Shen J; Lukacsko P; Friedhoff L
    J Clin Pharmacol; 2002 Feb; 42(2):198-204. PubMed ID: 11831543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
    Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet.
    Menon R; Tolbert D; Cefali E
    Biopharm Drug Dispos; 2007 Sep; 28(6):297-306. PubMed ID: 17571283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles.
    Suresh G; Manjunath K; Venkateswarlu V; Satyanarayana V
    AAPS PharmSciTech; 2007 Mar; 8(1):24. PubMed ID: 17408223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O; Alvarez JC
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast.
    Schug BS; Brendel E; Wonnemann M; Wolf D; Wargenau M; Dingler A; Blume HH
    Eur J Clin Pharmacol; 2002 May; 58(2):119-25. PubMed ID: 12012144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations.
    Rekhi GS; Eddington ND; Fossler MJ; Schwartz P; Lesko LJ; Augsburger LL
    Pharm Dev Technol; 1997 Feb; 2(1):11-24. PubMed ID: 9552427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
    Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
    Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.